Nwam LLC
- SEC CIK
- 0001655006
- Latest filing
- Jul 23, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by Nwam LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −1,000−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q4 2023 | 10,000 | $7.53K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,000 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,000 | $15.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $7.17K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,000 | $5.79K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,000 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,000 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,000 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,000 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10,000 | $22.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 10,000 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 10,000 | $99.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.